Global Supply Chain
Our industry-leading global supply chain includes finished dosage form manufacturing as well as active pharmaceutical ingredient (API) development and manufacturing. We also have biosimilars capabilities headquartered at our state-of-the-art biosimilar development center located in Liverpool, UK.
Actavis is committed to developing generic and brand pharmaceuticals products, as well as biosimilars that will drive future growth. Our R&D activities focus on products using solid dosage form, oral controlled and sustained release, transdermal, injectable, gel, semi-solid and oral transmucosal technologies.